IMC Chicago’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.7M Buy
300,000
+93,500
+45% +$11.3M 0.01% 887
2026
Q2
$27.5M Buy
206,500
+131,900
+177% +$14.9M 0.01% 892
2026
Q1
$8.31M Buy
74,600
+61,100
+453% +$7.23M ﹤0.01% 1419
2025
Q4
$1.82M Buy
+13,500
New +$1.47M ﹤0.01% 2507

Other funds holding ABVX

IMC Chicago's ABVX Position: Q3 2026 in Review

IMC Chicago increased its Abivax (ABVX) stake by 38% in Q3 2026, buying an estimated $4.05M and bringing the position to 120,966 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

IMC Chicago first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 317 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • IMC Chicago held 120,966 shares of Abivax worth $12M as of Q3 2026.
  • IMC Chicago bought 33,574 Abivax shares in Q3 2026, an estimated $4.05M.
  • Abivax made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #1504 holding.
  • IMC Chicago first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
  • 317 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.